These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10194115)

  • 1. Analysis of CSF amino acids in young patients with generalised refractory epilepsy during an add-on study with lamotrigine.
    Eriksson AS; O'Connor WT
    Epilepsy Res; 1999 Mar; 34(1):75-83. PubMed ID: 10194115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes.
    Bélanger S; Coulombe G; Carmant L
    Epilepsia; 1998 Aug; 39(8):878-83. PubMed ID: 9701380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vigabatrin (gamma-vinyl GABA) on amino acid levels in CSF of epileptic patients.
    Pitkänen A; Matilainen R; Ruutiainen T; Lehtinen M; Riekkinen P
    J Neurol Neurosurg Psychiatry; 1988 Nov; 51(11):1395-400. PubMed ID: 2853206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination vigabatrin and lamotrigine therapy for intractable epilepsy.
    Schapel GJ; Black AB; Lam EL; Robinson M; Dollman WB
    Seizure; 1996 Mar; 5(1):51-6. PubMed ID: 8777553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA and amino acid concentrations in lumbar CSF in patients with treated and untreated epilepsy.
    Crawford PM; Chadwick DW
    Epilepsy Res; 1987; 1(6):328-38. PubMed ID: 3504408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease.
    Jiménez-Jiménez FJ; Molina JA; Vargas C; Gómez P; Navarro JA; Benito-León J; Ortí-Pareja M; Gasalla T; Cisneros E; Arenas J
    J Neurol Sci; 1996 Sep; 141(1-2):39-44. PubMed ID: 8880690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of amino acid content of cerebrospinal fluid from patients with epilepsy.
    Araki K; Harada M; Ueda Y; Takino T; Kuriyama K
    Acta Neurol Scand; 1988 Dec; 78(6):473-9. PubMed ID: 3223234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of lamotrigine and vigabatrin treatment in children with severe epilepsy.
    Schapel GJ; Wallace SJ; Gordon GS
    Seizure; 1997 Dec; 6(6):479-83. PubMed ID: 9530945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low cerebrospinal fluid glutamate and glycine in refractory affective disorder.
    Frye MA; Tsai GE; Huggins T; Coyle JT; Post RM
    Biol Psychiatry; 2007 Jan; 61(2):162-6. PubMed ID: 16735030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory and excitatory amino acids in CSF of patients suffering from complex partial seizures during chronic treatment with gamma-vinyl GABA (vigabatrin).
    Halonen T; Lehtinen M; Pitkänen A; Ylinen A; Riekkinen PJ
    Epilepsy Res; 1988; 2(4):246-52. PubMed ID: 3143562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: effect of vigabatrin and carbamazepine monotherapies.
    Kälviäinen R; Halonen T; Pitkänen A; Riekkinen PJ
    J Neurochem; 1993 Apr; 60(4):1244-50. PubMed ID: 8095971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin and lamotrigine in refractory epilepsy.
    Stolarek I; Blacklaw J; Forrest G; Brodie MJ
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):921-4. PubMed ID: 8057114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine as an add-on drug in typical absence seizures.
    Ferrie CD; Robinson RO; Knott C; Panayiotopoulos CP
    Acta Neurol Scand; 1995 Mar; 91(3):200-2. PubMed ID: 7793236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
    Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
    Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
    Farrell K; Connolly MB; Munn R; Peng S; MacWilliam LM
    Pediatr Neurol; 1997 Apr; 16(3):201-5. PubMed ID: 9165509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study.
    Eriksson AS; Nergårdh A; Hoppu K
    Epilepsia; 1998 May; 39(5):495-501. PubMed ID: 9596201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy.
    Beran RG; Berkovic SF; Dunagan FM; Vajda FJ; Danta G; Black AB; Mackenzie R
    Epilepsia; 1998 Dec; 39(12):1329-33. PubMed ID: 9860069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters.
    Ryberg H; Askmark H; Persson LI
    Acta Neurol Scand; 2003 Jul; 108(1):1-8. PubMed ID: 12807386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.